Back
SBA Communications Vs. Kymera Therapeutics Industry Stock Comparison
Sell
40
SBAC
SBA Communications
Last Price:
193.08
Seasonality Move:
5.92%
Buy
63
KYMR
Kymera Therapeutics
Last Price:
34.28
Seasonality Move:
25.61%
Sell
40
SBA Communications (SBAC)
is a Sell
Is SBA Communications a Buy, Sell or Hold?
- The current SBA Communications [SBAC] share price is $193.21. The Score for SBAC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- SBAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $34.29. The Score for KYMR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SBAC Stock Price Chart
What is SBA Communications's stock price today?
-
The SBA Communications share price today is $193.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SBAC is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $34.29
The current trend is relatively stagnant and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SBAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.19 | Sell |
| Relative Strength Index (14 RSI): | 45.08 | Sell |
| Chaikin Money Flow: | 283432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (191.27 - 199.83) | Sell |
| Bollinger Bands (100): | (195.91 - 220.43) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.85 | Sell |
| Relative Strength Index (14 RSI): | 49.63 | Sell |
| Chaikin Money Flow: | 551618 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.72 - 37.26) | Sell |
| Bollinger Bands (100): | (32.73 - 40.25) | Sell |
SBAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 195.51 | Sell |
| 20-day SMA: | 195.35 | Sell |
| 50-day SMA: | 198.72 | Sell |
| 200-day SMA: | 216.09 | Sell |
| 8-day EMA: | 194.48 | Sell |
| 20-day EMA: | 195.09 | Sell |
| 50-day EMA: | 199.5 | Sell |
| 200-day EMA: | 217.19 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.72 | Buy |
| 20-day SMA: | 34.15 | Buy |
| 50-day SMA: | 35.3 | Sell |
| 200-day SMA: | 27.74 | Buy |
| 8-day EMA: | 33.28 | Buy |
| 20-day EMA: | 33.97 | Buy |
| 50-day EMA: | 35.05 | Sell |
| 200-day EMA: | 31.26 | Buy |
SBA Communications Earnings Growth & SBAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.11 per share, an increase this year of $4.91 per share, and an increase next year of $0.93 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.31 per share.
SBA Communications Technical Analysis
| May 28 | May 29 | May 30 | May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| May 28 | May 29 | May 30 | May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||